Mackenzie Financial’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-24,950
| Closed | -$70K | – | 1187 |
|
|
2020
Q1 | $70K | Buy |
+24,950
| New | +$70K | ﹤0.01% | 1037 |
|
|
2019
Q4 | – | Sell |
-36,000
| Closed | -$78K | – | 1190 |
|
|
2019
Q3 | $78K | Hold |
36,000
| – | – | ﹤0.01% | 987 |
|
|
2019
Q2 | $113K | Sell |
36,000
-4,050
| -10% | -$12.7K | ﹤0.01% | 1065 |
|
|
2019
Q1 | $149K | Hold |
40,050
| – | – | ﹤0.01% | 1189 |
|
|
2018
Q4 | $116K | Hold |
40,050
| – | – | ﹤0.01% | 1113 |
|
|
2018
Q3 | $105K | Buy |
40,050
+22,650
| +130% | +$59.4K | ﹤0.01% | 1083 |
|
|
2018
Q2 | $41K | Sell |
17,400
-4,948,362
| -100% | -$11.7M | ﹤0.01% | 996 |
|
|
2018
Q1 | $14.6M | Buy |
4,965,762
+112,400
| +2% | +$330K | 0.04% | 275 |
|
|
2017
Q4 | $13.3M | Sell |
4,853,362
-220,653
| -4% | -$605K | 0.03% | 310 |
|
|
2017
Q3 | $17.2M | Buy |
5,074,015
+1,423,471
| +39% | +$4.83M | 0.09% | 198 |
|
|
2017
Q2 | $9.02M | Sell |
3,650,544
-1,168,065
| -24% | -$2.89M | 0.05% | 256 |
|
|
2017
Q1 | $10.9M | Buy |
4,818,609
+130,784
| +3% | +$297K | 0.06% | 229 |
|
|
2016
Q4 | $9.94M | Sell |
4,687,825
-1,112,986
| -19% | -$2.36M | 0.06% | 232 |
|
|
2016
Q3 | $19.4M | Buy |
5,800,811
+738,986
| +15% | +$2.48M | 0.12% | 166 |
|
|
2016
Q2 | $15.9M | Buy |
5,061,825
+1,611,647
| +47% | +$5.06M | 0.09% | 208 |
|
|
2016
Q1 | $11.5M | Buy |
3,450,178
+590,578
| +21% | +$1.97M | 0.1% | 189 |
|
|
2015
Q4 | $10.1M | Buy |
+2,859,600
| New | +$10.1M | 0.06% | 240 |
|